Considering the discovered impact of high expression of ALKBH proteins on HNSCC development, we screened for ALKBH blockers among newly synthetized anthraquinone derivatives and demonstrated their potential to support standard anticancer therapy. This evidence concerns the gene ALKBH1 and head and neck squamous cell carcinoma.